Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
Mukherjee S, Hurt CN, Gwynne S, Bateman A, Gollins S, Radhakrishna G, Hawkins M, Canham J, Lewis W, Grabsch HI, Sharma RA, Wade W, Maggs R, Tranter B, Roberts A, Sebag-Montefiore D, Maughan T, Griffiths G, Crosby T. Mukherjee S, et al. Among authors: radhakrishna g. BMC Cancer. 2015 Feb 12;15:48. doi: 10.1186/s12885-015-1062-y. BMC Cancer. 2015. PMID: 25880814 Free PMC article. Clinical Trial.
Reply to the editorial on the HiLo trial.
Gill V, Gerrard G, Radhakrishna G, Khan Z, Williamson D. Gill V, et al. Among authors: radhakrishna g. Clin Oncol (R Coll Radiol). 2009 Feb;21(1):72. doi: 10.1016/j.clon.2008.10.001. Epub 2008 Nov 7. Clin Oncol (R Coll Radiol). 2009. PMID: 18996000 No abstract available.
Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer.
Thomas M, Mortensen HR, Hoffmann L, Møller DS, Troost EGC, Muijs CT, Berbee M, Bütof R, Nicholas O, Radhakrishna G, Defraene G, Nafteux P, Nordsmark M, Haustermans K. Thomas M, et al. Among authors: radhakrishna g. Radiother Oncol. 2021 Mar;156:102-112. doi: 10.1016/j.radonc.2020.11.032. Epub 2020 Dec 5. Radiother Oncol. 2021. PMID: 33285194
Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres.
Hoffmann L, Mortensen H, Shamshad M, Berbee M, Bizzocchi N, Bütof R, Canters R, Defraene G, Ehmsen ML, Fiorini F, Haustermans K, Hulley R, Korevaar EW, Clarke M, Makocki S, Muijs CT, Murray L, Nicholas O, Nordsmark M, Radhakrishna G, Thomas M, Troost EGC, Vilches-Freixas G, Visser S, Weber DC, Møller DS. Hoffmann L, et al. Among authors: radhakrishna g. Radiother Oncol. 2022 Jul;172:32-41. doi: 10.1016/j.radonc.2022.04.029. Epub 2022 May 2. Radiother Oncol. 2022. PMID: 35513132 Free article. Clinical Trial.
84 results